Evaluating the effects of herbal Garlic supplementation on clinical outcomes and quality of life inpatients with Chronic Obstructive Pulmonary Disease (COPD)

Evaluating the effects of Garlic supplementation on clinical outcomes and quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151227025726N36

Enrollment

Registered

2024-04-15

Start date

2024-05-05

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease. Other chronic obstructive pulmonary disease

Interventions

Intervention 1: Intervention group: Patients in the intervention group received capsules containing 500mg of garlic extract (prepared by Goldaru company) twice a day for two months. Intervention 2: Co

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients who are diagnosed with COPD. Diagnosis is based on FEV1/FVC ratio less than 0.7.

Exclusion criteria

Exclusion criteria: Allergy to garlic Patients who need surgery Pregnant and lactating patients Cancer patients Patients with thyroid malignancy Asthma Patients who take anticoagulant drugs AIDS patients

Design outcomes

Primary

Measure	Time frame
Evaluating the effects of Garlic supplementation on clinical outcomes and quality of life in patients with Chronic Obstructive Pulmonary Disease. Timepoint: ?Beginning of the study, End of the first month, End of the second month. Method of measurement: mMRC, BODE and SGRQ questionnaires.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamin Iranikhah

Shahid Beheshti University of Medical Sciences

samin98ir@gmail.com+98 21 2712 2227

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026